Citizenplus Pharmaceuticals Private Limited, a active private limited company, was established on 22 April 2015 in Jubilee Hills, Telangana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24100TG2015PTC098583. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹2.93 Cr.
It upholds a compliant status. Employing 26 professional, Its leadership includes Sreehari Kumar Annamraju (Managing Director), Venkata Radh Krishna Kishore Annamraju (Director). Past directors included Bala Venkata Reddy Turpuseema, Sreehari Kumar Annamraju, Aparna Annamaraju. It holds ₹9.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Ff5, Fourth Floor, Empire Square Road No.36,, Jubilee Hills, Telangana, 500033.
U24100TG2015PTC098583
098583
22 April 2015
₹5.00 Cr
₹2.93 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Citizenplus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sreehari Kumar Annamraju | Managing Director | 19 Nov 2019 | Current |
| Venkata Radh Krishna Kishore Annamraju | Director | 22 Apr 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Apr 2025 | Past |
| Pramod Abcsdd | Additional Director | 27 May 2020 | Past |
| Pramod Abcsdd | Director | 10 Nov 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Citizenplus Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 116.16% increase. The company also saw a substantial fall in profitability, with a 21.92% decrease in profit. The company's net worth Soared by an impressive increase of 226.22%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Citizenplus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹9,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Dec 2021 | Others | ₹9.50 M | Open |
Explore comprehensive loan charge details -
Citizenplus Pharmaceuticals has a workforce of 26 employees as of Jun 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Citizenplus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Citizenplus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Citizenplus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.
Progress on Citizenplus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad. was documented.
Progress on A charge with Others amounted to Rs. 0.95 Cr with Charge ID 100510169 was registered on 06 Dec 2021. was documented.
The activity Sreehari Kumar Annamraju was appointed as a Managing Director was appointed as a Managing Director on 19 Nov 2019 & has been associated with this company since 6 years 27 days . was completed.
The activity Venkata Radh Krishna Kishore Annamraju was appointed as a Director was appointed as a Director on 22 Apr 2015 & has been associated with this company since 10 years 7 months . was completed.
Progress on Citizenplus Pharmaceuticals Private Limited was registered on 22 Apr 2015 with Roc Hyderabad & aged 10 years 7 months as per MCA records. was documented.
The CIN of Citizenplus Pharmaceuticals Private Limited is U24100TG2015PTC098583.
Citizenplus Pharmaceuticals Private Limited is headquartered at Ff5, Fourth Floor, Empire Square Road No.36,, Jubilee Hills, Telangana, 500033.
Citizenplus Pharmaceuticals Private Limited was incorporated on 22 April 2015.
The current directors of Citizenplus Pharmaceuticals Private Limited are
The primary industry of Citizenplus Pharmaceuticals Private Limited is Trade.
Citizenplus Pharmaceuticals Private Limited is unlisted.
The authorized capital of Citizenplus Pharmaceuticals Private Limited is ₹5.00 Cr, and the paid-up capital is ₹2.93 Cr.
The compliance status of Citizenplus Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX